Drug Profile
FBR 001
Alternative Names: FBR-001; Mers-CoV (FBR-001)Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Fabentech
- Class COVID-19 vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Middle East respiratory syndrome coronavirus
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Middle-East-respiratory-syndrome-coronavirus(Prevention) in France (Parenteral)
- 22 Jul 2016 Early research in Middle East respiratory syndrome coronavirus (Prevention) in France (Parenteral)